Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-040012
Filing Date
2014-06-09
Accepted
2014-06-09 20:11:51
Documents
1
Period of Report
2014-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3928
  Complete submission text file 0001209191-14-040012.txt   5287
Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9640 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Issuer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONYX PHARMACEUTICALS, INC. 2100 POWELL ST., 12TH FLOOR EMERYVILLE CA 94608
Business Address
Fust Matthew K (Reporting) CIK: 0001397266 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36112 | Film No.: 14900371